New Stock Epinephrine and Stock Inhaler Toolkits Improve Safety of Students with Anaphylaxis and Asthma
MILWAUKEE, Aug. 17, 2023 /PRNewswire-PRWeb/ -- New stock inhaler and stock epinephrine toolkits from The School-Based Asthma, Allergy and Anaphylaxis Committee (SA3MPRO™) of the American Academy of Allergy, Asthma & Immunology (AAAAI) empower schools to develop and implement high-quality stock epinephrine stock inhaler policies.
- New stock inhaler and stock epinephrine toolkits from the AAAAI provide critical emergency care for students with allergies and asthma.
- MILWAUKEE, Aug. 17, 2023 /PRNewswire-PRWeb/ -- New stock inhaler and stock epinephrine toolkits from The School-Based Asthma, Allergy and Anaphylaxis Committee (SA3MPRO™) of the American Academy of Allergy, Asthma & Immunology (AAAAI) empower schools to develop and implement high-quality stock epinephrine stock inhaler policies.
- Despite asthma and anaphylactic allergies impacting millions of children in the American school system, the development and implementation of stock inhaler and epinephrine policies remains slow-going.
- The SA3MPRO™ stock inhaler and stock epinephrine toolkits seek to mitigate barriers and address state-level differences in policy implementation.